,
Puig-Barberà, Joan http://orcid.org/0000-0001-5783-0409
Mira-Iglesias, Ainara
Burtseva, Elena
Cowling, Benjamin J.
Serhat, Unal
Ruiz-Palacios, Guillermo Miguel
Launay, Odile
Kyncl, Jan
Koul, Parvaiz
Siqueira, Marilda M.
Sominina, Anna
Article History
Received: 13 December 2018
Accepted: 24 April 2019
First Online: 14 May 2019
Ethics approval and consent to participate
: The GIHSN study protocol was approved by the institutional review board of each participating site: in India, the Institutional Ethics Committee of the Sher-i-Kashmir Institute of Medical Sciences, Srinagar; in Beijing, China, “The Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster”; in France, “CPP Ile de France IV, Saint-Louis hospital in Paris”; in the Czech Republic, the “Ethics Committee of the Hospital Na Bulovce”; in Turkey, the “Hacettepe University Non-interventional Clinical Research Ethics Board”; in Moscow, Russia, “The local Ethic Committee of Hospital #1 for Infectious Diseases of Moscow Health Department”; in Brazil (Fortaleza & Curitiba), the “Ethical Committee of the Evandro Chagas National Institute of Infectology (INI-Fiocruz)”; in Mexico, the “Research Ethics Committee of the National Institute of Medical Science and Nutrition Salvador Zubirán” & “Research Committee of the National Institute of Medical Science and Nutrition Salvador Zubirán”; in St Petersburg, Russia, “Local Ethical Committee under the FGBU ‘Research Institute of Influenza’ of the Ministry of Health of the Russian Federation”; and in Spain, the “Research Ethics Committee of the General Directorate of Public Health and High Center for Public Health Research (CEI DGSP-CSISP)”. All subjects or legal representatives provided written or (if approved by the associated institutional review board) oral informed consent; consent to participate was collected from the parents/guardians of any participants under 16 years of age.
: Not applicable.
: BJC received grants from Sanofi Pasteur unrelated to the submitted work. PK has served as a consultant to Sanofi, Zydus, and Cadila. All other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.